Major journals, first or last author from the Div. of LabMed
Amrutkar M, Guttorm SJT, Finstadsveen AV, Labori KJ, Eide L, Rootwelt H, Elgstøen KBP, Gladhaug IP, Verbeke CS(2024) Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer Mol Oncol(in press) DOI 10.1002/1878-0261.13759, PubMed 39545923
Gehin JE, Klaasen RA, Klami Kristianslund E, Jyssum I, Sexton J, Warren DJ, Aletaha D, Haavardsholm EA, Syversen SW, Goll GL, Bolstad N(2024) Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial RMD Open, 10(4) DOI 10.1136/rmdopen-2024-004888, PubMed 39537558
Gopalakrishnan RP, Østrøm MS, Skjeldal FM, Bakke O, Bogen B, Huszthy PC(2024) B Cells With Complementary B Cell Receptors Can Kill Each Other Eur J Immunol, e202350890(in press) DOI 10.1002/eji.202350890, PubMed 39520365